Filing Details

Accession Number:
0001209191-15-004180
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-01-14 16:06:09
Reporting Period:
2015-01-12
Filing Date:
2015-01-14
Accepted Time:
2015-01-14 16:06:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1503802 Karyopharm Therapeutics Inc. KPTI Pharmaceutical Preparations (2834) 263931704
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1270734 Deepika Pakianathan C/O Delphi Ventures, 300 Sand Hill Rd.,
Building 1, Ste. 135
Menlo Park CA 94025
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-01-12 45,014 $33.00 2,241,123 No 4 P Indirect By Delphi Ventures VIII, L.P.
Common Stock Acquisiton 2015-01-12 440 $33.00 21,883 No 4 P Indirect By Delphi BioInvestments VIII, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Delphi Ventures VIII, L.P.
No 4 P Indirect By Delphi BioInvestments VIII, L.P.
Footnotes
  1. The Reporting Person is a managing member of Delphi Management Partners VIII, L.L.C. ("DMP"), the general partner of each of Delphi Ventures VIII, L.P. and Delphi BioInvestments VIII, L.P. (collectively, the "Delphi Funds"). As a managing member of DMP, the Reporting Person shares voting and investment power over the shares held by the Delphi Funds and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such shares held by the Delphi Funds, except to the extent of her proportionate pecuniary interest therein.